Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Denosumab Biosimilar – Anti-RANKL mAb – Research Grade

Isotype:
IgG2, Kappa

€120.00

100ug + 120 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
Denosumab Biosimilar – Anti-RANKL mAb – Research Grade binds to CD254 / RANKL / TNFSF11, N-Fc, recombinant protein in indirect ELISA Assay

Denosumab Biosimilar - Anti-RANKL mAb - Research Grade

Product name Denosumab Biosimilar - Anti-RANKL mAb - Research Grade
Source DrugBank DB06643
Species Human
Molecular weight 144kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Denosumab,Denosumab,RANKL,anti-RANKL
Reference PX-TA1018
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2Kappa
Clonality Monoclonal Antibody
Product name Denosumab Biosimilar - Anti-RANKL mAb - Research Grade
Source DrugBank DB06643
Species Human
Expression system Mammalian cells
Molecular weight 144kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Denosumab,Denosumab,RANKL,anti-RANKL
Reference PX-TA1018
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG2Kappa
Clonality Monoclonal Antibody

General information about Denosumab

Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption markers in patients with a variety of metastatic tumors and is being investigated in multiple clinical trials for the prevention and treatment of bone metastases. Chemically, it consists of 2 heavy and 2 light chains. Each light chain consists of 215 amino acids. Each heavy chain consists of 448 amino acids with 4 intramolecular disulfides.This product is for research use only.

Denosumab Biosimilar – Anti-RANKL mAb – Research Grade binds to CD254 / RANKL / TNFSF11, N-Fc, recombinant protein in indirect ELISA Assay

Denosumab Biosimilar – Anti-RANKL mAb – Research Grade binds to CD254 / RANKL / TNFSF11, N-Fc, recombinant protein in indirect ELISA Assay

Immobilized CD254 / RANKL / TNFSF11, N-Fc, recombinant protein (cat. No.PX-P5597) at 5µg/mL (100µL/well) can bind to Denosumab Biosimilar- Anti-RANKL mAb- Research Grade (cat. No.PX-TA1018) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Denosumab Biosimilar – Anti-RANKL mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products